The Impact of Equine-Assisted Psychotherapy on Depression, Anxiety, and Stress in Patients with Substance Use Disorder in a Psychiatric Hospital

NCT06652269 | Completed

• 1 other identifier: 8870-VIII/2013
• Study Type: observational
• Target: 68
• Locations: 1 country
• Sites: 1

Brief Summary

This study aims to assess whether an EAP program affects anxiety, depression, and stress, which are often associated with substance use disorder. The management of these conditions has a major impact on the control of the addiction.

Conditions

Substance Abuse Disorder; Anxiety; Depression Secondary to Other Disease

Keywords

Equine asssited psychotherapy; substance use disorder; psychotherapy

Outcome Measures

Primary Outcomes (4)

• State-Trait Anxiety Inventory (STAI)

  The State-Trait Anxiety Inventory (STAI) is an instrument evaluating the current level of anxiety and personality traits. It was translated into the czech in 2019 by Figalová (2019). Scoring is done using a template, and the range of final scores is 20-80 for each subscale. The higher the score, the higher the level of anxiety or fear. The scores can be divided into three categories-no or low perceived anxiety/anxiousness, moderate anxiety/anxiousness, and high anxiety/anxiousness (Müllner et. al, 1980; Figalová, 2019).

  through study completion, an average of 18 months

• Depression Anxiety and Stress Scale 21 (DASS-21)

  The DASS-21 scale has 21 items. Respondents rate their experiences in the past week on a four-point Likert scale (0 = not at all; 1 = sometimes; 2 = often; 3 = almost always). The questionnaire has three subscales: depression, anxiety, and stress. The depression subscale focuses on the patient's low mood, anhedonia, hopelessness, self-deprecation, devaluation of life, and decreased motivation. The anxiety subscale focuses on physiological arousal, subjective feelings of tension, situational anxiety, and fear. The stress subscale measures the inability to relax, tension, impatience, and irritability. For all three subscales, scores are categorized as normal, mild, moderate, severe, and extremely severe (Lovibond \& Lovibond, 1995).

  through study completion, an average of 18 months

• Perceived Stress Scale (PSS)

  The Perceived Stress Scale (PSS) is a self-report scale to measure non-specific perceived stress (Cohen et. al, 1983). It is a short scale that is easy to administer, can be administered individually or in groups, is easy to score, and has satisfactory psychometric properties despite its small size. It is the most commonly used psychological instrument to measure perceived stress (Cohen \& Janicki-Deverts, 2009). The scale consists of 10 items. Within the PSS, scores can be divided into three categories: low stress, moderate stress, and high perceived stress (Buršíková et al., 2018).

  through study completion, an average of 18 months

• Beck Anxiety Inventory (BAI)

  The Beck Anxiety Inventory (BAI; \[Beck et al., 1988\]) is a self-report instrument useful for assessing general anxiety in patients with anxiety disorders or depression. The BAI allows for the assessment of actual levels of anxiety. It assesses the expression of both somatic and psychological symptoms of anxiety. The questionnaire has excellent internal consistency (Cronbach's alpha = 0.92) and satisfactory test-retest performance (r = 0.75) at one week. The categories can be divided into minimal anxiety, mild anxiety, moderate anxiety, and severe anxiety.

  through study completion, an average of 18 months

Study Arms (2)

Experimental

Group with equine-assisted psychotherapy

Other: Psychopharmacology intervention

Control

Group with psychotherapy

Interventions

Psychopharmacology intervention OTHER

Psychotherapy with horses

Experimental

Eligibility Criteria

• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

Patients of psychiatric hospital with substance use disorder

You may qualify if:

• Patients of psychiatric hospital of Kosmonosy with substance use disorder

Sponsors & Collaborators

• Czech University of Life Sciences Prague: lead

Study Sites (1)

Psychiatrická nemocnice Kosmonosy

Kosmonosy, 29306, Czechia

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

Psychometric scales

MeSH Terms

Conditions

Substance-Related Disorders; Anxiety Disorders

Condition Hierarchy (Ancestors)

Chemically-Induced Disorders; Mental Disorders

Study Officials

• Kristýna Machová, associate professor

  Czech university of life sciences

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: CASE CONTROL
• Time Perspective: PROSPECTIVE
• Target Duration: 4 Weeks
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Associate professor

Study Record Dates

• First Submitted: October 10, 2024
• First Posted: October 22, 2024
• Study Start: March 23, 2022
• Primary Completion: December 15, 2023
• Study Completion: December 15, 2023
• Last Updated: October 22, 2024

Record last verified: 2024-10

Data Sharing

• IPD Sharing: Will share
• Shared Documents: ANALYTIC CODE
• Time Frame: Unending- All data are available on Mendeley database https://data.mendeley.com/datasets/bng79xc6pc/1
• Access Criteria: All data are available on Mendeley database https://data.mendeley.com/datasets/bng79xc6pc/1

Locations

CZ (1)